Drugmaker Fights Claims Over 'Misleading' IPO Statements

By Emilie Ruscoe · July 11, 2025, 12:29 PM EDT

Investors in biopharmaceutical company BioAge Labs Inc. mischaracterized certain statements the company made in an effort to allege securities fraud after the company hit the brakes on a clinical trial for...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re BioAge Labs, Inc., Securities Litigation

Case Number

3:25-cv-00196

Court

California Northern

Nature of Suit

Securities/Commodities

Date Filed

January 07, 2025